High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation - PubMed (original) (raw)
. 2003 Mar 1;101(5):1759-68.
doi: 10.1182/blood-2002-03-0767. Epub 2002 Oct 24.
Affiliations
- PMID: 12406897
- DOI: 10.1182/blood-2002-03-0767
Free article
High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation
Bernhard Schiedlmeier et al. Blood. 2003.
Free article
Abstract
Ectopic retroviral expression of homeobox B4 (HOXB4) causes an accelerated and enhanced regeneration of murine hematopoietic stem cells (HSCs) and is not known to compromise any program of lineage differentiation. However, HOXB4 expression levels for expansion of human stem cells have still to be established. To test the proposed hypothesis that HOXB4 could become a prime tool for in vivo expansion of genetically modified human HSCs, we retrovirally overexpressed HOXB4 in purified cord blood (CB) CD34+ cells together with green fluorescent protein (GFP) as a reporter protein, and evaluated the impact of ectopic HOXB4 expression on proliferation and differentiation in vitro and in vivo. When injected separately into nonobese diabetic-severe combined immunodeficient (NOD/SCID) mice or in competition with control vector-transduced cells, HOXB4-overexpressing cord blood CD34+ cells had a selective growth advantage in vivo, which resulted in a marked enhancement of the primitive CD34+ subpopulation (P =.01). However, high HOXB4 expression substantially impaired the myeloerythroid differentiation program, and this was reflected in a severe reduction of erythroid and myeloid progenitors in vitro (P <.03) and in vivo (P =.01). Furthermore, HOXB4 overexpression also significantly reduced B-cell output (P <.01). These results show for the first time unwanted side effects of ectopic HOXB4 expression and therefore underscore the need to carefully determine the therapeutic window of HOXB4 expression levels before initializing clinical trials.
Similar articles
- Enforced adenoviral vector-mediated expression of HOXB4 in human umbilical cord blood CD34+ cells promotes myeloid differentiation but not proliferation.
Brun AC, Fan X, Björnsson JM, Humphries RK, Karlsson S. Brun AC, et al. Mol Ther. 2003 Oct;8(4):618-28. doi: 10.1016/s1525-0016(03)00237-5. Mol Ther. 2003. PMID: 14529835 - Lentiviral-mediated HoxB4 expression in human embryonic stem cells initiates early hematopoiesis in a dose-dependent manner but does not promote myeloid differentiation.
Unger C, Kärner E, Treschow A, Stellan B, Felldin U, Concha H, Wendel M, Hovatta O, Aints A, Ahrlund-Richter L, Dilber MS. Unger C, et al. Stem Cells. 2008 Oct;26(10):2455-66. doi: 10.1634/stemcells.2007-0876. Epub 2008 Jul 10. Stem Cells. 2008. PMID: 18617691 - Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo.
Buske C, Feuring-Buske M, Antonchuk J, Rosten P, Hogge DE, Eaves CJ, Humphries RK. Buske C, et al. Blood. 2001 Apr 15;97(8):2286-92. doi: 10.1182/blood.v97.8.2286. Blood. 2001. PMID: 11290589 - [Ex vivo expansion of human hematopoietic stem cells by passive transduction of the HOXB4 homeoprotein].
Amsellem S, Fichelson S. Amsellem S, et al. J Soc Biol. 2006;200(3):235-41. doi: 10.1051/jbio:2006027. J Soc Biol. 2006. PMID: 17417138 Review. French. - Mechanism of action of HOXB4 on the hematopoietic differentiation of embryonic stem cells.
Forrester LM, Jackson M. Forrester LM, et al. Stem Cells. 2012 Mar;30(3):379-85. doi: 10.1002/stem.1036. Stem Cells. 2012. PMID: 22267295 Review.
Cited by
- Hox genes are crucial regulators of periosteal stem cell identity.
Leclerc K, Remark LH, Ramsukh M, Josephson AM, Palma L, Parente PEL, Sambon M, Lee S, Lopez EM, Morgani SM, Leucht P. Leclerc K, et al. Development. 2023 Mar 15;150(6):dev201391. doi: 10.1242/dev.201391. Epub 2023 Mar 24. Development. 2023. PMID: 36912250 Free PMC article. - Human amniotic mesenchymal stromal cells support the ex vivo expansion of cord blood hematopoietic stem cells.
Orticelli V, Papait A, Vertua E, Bonassi Signoroni P, Romele P, Di Pietro L, Magatti M, Teofili L, Silini AR, Parolini O. Orticelli V, et al. Stem Cells Transl Med. 2021 Nov;10(11):1516-1529. doi: 10.1002/sctm.21-0130. Epub 2021 Jul 29. Stem Cells Transl Med. 2021. PMID: 34327849 Free PMC article. - HOXB4 Promotes Hemogenic Endothelium Formation without Perturbing Endothelial Cell Development.
Teichweyde N, Kasperidus L, Carotta S, Kouskoff V, Lacaud G, Horn PA, Heinrichs S, Klump H. Teichweyde N, et al. Stem Cell Reports. 2018 Mar 13;10(3):875-889. doi: 10.1016/j.stemcr.2018.01.009. Epub 2018 Feb 15. Stem Cell Reports. 2018. PMID: 29456178 Free PMC article. - Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor.
Tan YT, Ye L, Xie F, Beyer AI, Muench MO, Wang J, Chen Z, Liu H, Chen SJ, Kan YW. Tan YT, et al. Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):2180-2185. doi: 10.1073/pnas.1718446115. Epub 2018 Jan 31. Proc Natl Acad Sci U S A. 2018. PMID: 29386396 Free PMC article. - Enhancement of mouse hematopoietic stem/progenitor cell function via transient gene delivery using integration-deficient lentiviral vectors.
Alonso-Ferrero ME, van Til NP, Bartolovic K, Mata MF, Wagemaker G, Moulding D, Williams DA, Kinnon C, Waddington SN, Milsom MD, Howe SJ. Alonso-Ferrero ME, et al. Exp Hematol. 2018 Jan;57:21-29. doi: 10.1016/j.exphem.2017.09.003. Epub 2017 Sep 11. Exp Hematol. 2018. PMID: 28911908 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials